In this week’s episode of “Podnosis,” we’re diving deep into the current landscape of clinical trials in the U.S.

Establishing growing body of preclinical data evaluating the DNase-based oncology platform across a number of high-value ...

The study highlights the need for randomized clinical trials to confirm the efficacy of GLP-1 agonists in treating AUD and ...

The research, led by Dr. Daniel Myran, a Canada Research Chair in Social Accountability at the University of Ottawa, followed ...

Mavorixafor was generally well tolerated as a monotherapy and in combination with G-CSF, with no drug-related serious adverse ...

Researchers not involved in the study cautioned it does not prove the popular weight-loss drugs work to limit drinking. Sarah ...

On Wednesday, BioNTech SE (NASDAQ:BNTX) agreed to acquire Biotheus, a clinical-stage biotechnology company focused on ...

Both Big Pharma Sanofi and AI-focused biotech Formation Bio plan on using Muse in upcoming clinical trials, with an initial ...

Marie Rahne, director, and Douglas Yee, MD, interim medical director of the Minnesota Cancer Clinical Trial Network spoke to Becker's about how their organization is broadening the scope of cancer ...

The agency has placed a partial hold on the phase 2a PORTOLA trial evaluating the selective immunoproteasome inhibitor ...

An immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant in a Stanford ...

Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced its financial results and operational update for ...